Cargando…

SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay

OBJECTIVES: SARS-CoV-2 T-cell response characterization represents a crucial issue for defining the role of immune protection against COVID-19. The aim of the study was to assess the SARS-CoV-2 T-cell response in a cohort of COVID-19 convalescent patients and in a group of unexposed subjects. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cassaniti, Irene, Percivalle, Elena, Bergami, Federica, Piralla, Antonio, Comolli, Giuditta, Bruno, Raffaele, Vecchia, Marco, Sambo, Margherita, Colaneri, Marta, Zuccaro, Valentina, Benazzo, Marco, Robotti, Carlo, Calastri, Anna, Maiorano, Eugenia, Ferrari, Alessandro, Cambiè, Giuseppe, Baldanti, Fausto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016542/ https://www.ncbi.nlm.nih.gov/pubmed/33813122 http://dx.doi.org/10.1016/j.cmi.2021.03.010

Ejemplares similares

Clinical, virological and immunological evolution of the olfactory and gustatory dysfunction in COVID-19
por: Maiorano, Eugenia, et al.
Publicado: (2022)

Characterization of Varicella-Zoster (VZV) Specific T Cell Response in Healthy Subjects and Transplanted Patients by Using Enzyme Linked Immunospot (ELISpot) Assays
por: Cassaniti, Irene, et al.
Publicado: (2021)

Evaluation of EBV- and HCMV-Specific T Cell Responses in Systemic Lupus Erythematosus (SLE) Patients Using a Normalized Enzyme-Linked Immunospot (ELISPOT) Assay
por: Cassaniti, Irene, et al.
Publicado: (2019)

SARS-CoV-2 Virologic and Immunologic Correlates in Patients with Olfactory and Taste Disorders
por: Benazzo, Marco, et al.
Publicado: (2020)

Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection
por: Sherina, Natalia, et al.
Publicado: (2021)

Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers
por: Bergami, Federica, et al.
Publicado: (2022)

Humoral and cell-mediated response against SARS-CoV-2 variants elicited by mRNA vaccine BNT162b2 in healthcare workers: a longitudinal observational study
por: Cassaniti, Irene, et al.
Publicado: (2022)

Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up
por: Lasagna, Angioletta, et al.
Publicado: (2023)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
por: Piralla, Antonio, et al.
Publicado: (2011)

Authors’ response: COVID-19: how accurate are seroprevalence studies?
por: Cassaniti, Irene, et al.
Publicado: (2020)

EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count
por: Paolucci, Stefania, et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit
por: Colaneri, M., et al.
Publicado: (2020)

Immunity to SARS-CoV-2 up to 15 months after infection
por: Marcotte, Harold, et al.
Publicado: (2022)

Machine Learning-based Voice Assessment for the Detection of Positive and Recovered COVID-19 Patients
por: Robotti, Carlo, et al.
Publicado: (2021)

Thirteen Years of Phleboviruses Circulation in Lombardy, a Northern Italy Region
por: Percivalle, Elena, et al.
Publicado: (2021)

Impact of Viral Decontamination Method on Cytokine Profile of COVID-19 Patients
por: Magrì, Davide, et al.
Publicado: (2021)

Residual SARS-CoV-2 RNA in nasal swabs of convalescent COVID-19 patients: Is prolonged quarantine always justified?
por: Piralla, Antonio, et al.
Publicado: (2021)

ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients
por: Zavaglio, Federica, et al.
Publicado: (2023)

Real-life lack of evidence of viable SARS-CoV-2 transmission via inanimate surfaces: The SURFACE study
por: Sammartino, José Camilla, et al.
Publicado: (2023)

Evaluation of the Neutralizing Antibodies Response against 14 SARS-CoV-2 Variants in BNT162b2 Vaccinated Naïve and COVID-19 Positive Healthcare Workers from a Northern Italian Hospital
por: Sammartino, Josè Camilla, et al.
Publicado: (2022)

Impact of pathogen reduction technology on neutralizing antibody titer in COVID-19 convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2022)

Deep learning and machine learning-based voice analysis for the detection of COVID-19: A proposal and comparison of architectures
por: Costantini, Giovanni, et al.
Publicado: (2022)

High Frequencies of Functional Virus-Specific CD4(+) T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders
por: Mele, Dalila, et al.
Publicado: (2021)

Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy
por: Colaneri, M., et al.
Publicado: (2020)

SARS-CoV-2 positivity in rectal swabs: implication for possible transmission
por: Novazzi, Federica, et al.
Publicado: (2020)

Swine Influenza A(H3N2) Virus Infection in Immunocompromised Man, Italy, 2014
por: Piralla, Antonio, et al.
Publicado: (2015)

Macrophages and Monocytes: “Trojan Horses” in COVID-19
por: Percivalle, Elena, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 in blood donors from the Lodi Red Zone and adjacent Lodi metropolitan and suburban area
por: Cassaniti, Irene, et al.
Publicado: (2021)

Molecular Epidemiology of Rhinovirus/Enterovirus and Their Role on Cause Severe and Prolonged Infection in Hospitalized Patients
por: Giardina, Federica A. M., et al.
Publicado: (2022)

Genetic divergence of influenza A NS1 gene in pandemic 2009 H1N1 isolates with respect to H1N1 and H3N2 isolates from previous seasonal epidemics
por: Campanini, Giulia, et al.
Publicado: (2010)

Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment
por: Lasagna, A., et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020
por: Percivalle, Elena, et al.
Publicado: (2020)

Serum and breastmilk SARS-CoV-2 specific antibodies following BNT162b2 vaccine: prolonged protection from SARS-CoV-2 in newborns and older children
por: Ricciardi, Alessandra, et al.
Publicado: (2022)

Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study
por: Lasagna, A., et al.
Publicado: (2022)

Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern
por: Lasagna, A., et al.
Publicado: (2022)

Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients
por: Gerna, Giuseppe, et al.
Publicado: (2007)

Effect of a Third Dose of SARS-CoV-2 mRNA BNT162b2 Vaccine on Humoral and Cellular Responses and Serum Anti-HLA Antibodies in Kidney Transplant Recipients
por: Cassaniti, Irene, et al.
Publicado: (2022)

Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy
por: Colaneri, Marta, et al.
Publicado: (2022)

SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
por: Rovida, Francesca, et al.
Publicado: (2021)

Impact of quarantine and face masks on ragweed‐induced oculorhinits during the COVID‐19 pandemic in Northern Italy
por: Dubini, Marco, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bnj3aa3uca09i0t0vk8va9tr9s